AbCellera Biologics (ABCL) Institutional Ownership $4.18 -0.12 (-2.79%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.22 +0.04 (+0.84%) As of 05:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for AbCellera Biologics (NASDAQ:ABCL)CurrentInstitutional OwnershipPercentage61.42%Number ofInstitutional Buyers(last 12 months)69TotalInstitutional Inflows(last 12 months)$74.87MNumber ofInstitutional Sellers(last 12 months)38TotalInstitutional Outflows(last 12 months)$52.58M Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ABCL Institutional Buying and Selling by Quarter AbCellera Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc20,000$69K0.0%N/A0.007% 8/16/2025 Headlands Technologies LLC37,795$130K0.0%N/A0.013% 8/15/2025 Lantern Wealth Advisors LLC15,000$51K0.0%N/A0.005% 8/15/2025 Lazard Asset Management LLC509,794$1.75M0.0%-38.8%0.171% 8/15/2025 Brevan Howard Capital Management LP65,607$225K0.0%-53.6%0.022% 8/15/2025 Bank of America Corp DE224,365$770K0.0%+1,304.5%0.075% 8/14/2025 Orbimed Advisors LLC3,344,568$11.47M0.3%-20.0%1.119% 8/14/2025 Raymond James Financial Inc.28,049$96K0.0%+17.0%0.009% 8/14/2025 Federated Hermes Inc.53,000$182K0.0%-94.4%0.018% 8/13/2025 Invesco Ltd.37,112$127K0.0%+53.7%0.012% Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Virtus Investment Advisers LLC29,852$102K0.0%-46.4%0.010% 8/13/2025 Norges Bank630,938$2.16M0.0%N/A0.211% 8/13/2025 Scotia Capital Inc.29,024$100K0.0%+80.6%0.010% 8/12/2025 XTX Topco Ltd66,444$228K0.0%+46.8%0.022% 8/12/2025 American Century Companies Inc.113,760$390K0.0%-2.5%0.038% 8/12/2025 JPMorgan Chase & Co.135,441$465K0.0%-33.7%0.045% 8/8/2025 Creative Planning41,003$141K0.0%+6.9%0.014% 8/8/2025 Geode Capital Management LLC363,188$1.25M0.0%+3.5%0.122% 8/5/2025 Bank of Montreal Can70,089$240K0.0%+46.2%0.023% 8/5/2025 State of Michigan Retirement System49,225$169K0.0%N/A0.016% 8/1/2025 Envestnet Asset Management Inc.18,310$63K0.0%-16.6%0.006% 8/1/2025 Green Alpha Advisors LLC29,103$100K0.1%-22.3%0.010% 7/31/2025 Moloney Securities Asset Management LLC12,000$41K0.0%-16.7%0.004% 7/31/2025 Caitong International Asset Management Co. Ltd10,127$35K0.0%N/A0.003% 7/29/2025 TrueMark Investments LLC111,119$381K0.1%-3.7%0.037% 7/21/2025 J2 Capital Management Inc13,100$45K0.0%N/A0.004% 7/17/2025 XML Financial LLC34,500$118K0.0%N/A0.012% 7/16/2025 Signaturefd LLC9,431$32K0.0%-42.7%0.003% 7/15/2025 Ballentine Partners LLC23,689$81K0.0%N/A0.008% 7/9/2025 GEM Asset Management LLC20,000$69K0.0%-33.3%0.007% 7/7/2025 Salem Investment Counselors Inc.15,550$53K0.0%-80.3%0.005% 6/27/2025 Goldman Sachs Group Inc.86,483$193K0.0%-71.2%0.029% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC15,671,063$34.95M0.0%+248.2%5.251% 5/16/2025 Goldman Sachs Group Inc.86,483$193K0.0%-71.2%0.029% 5/15/2025 Royal Bank of Canada387,031$863K0.0%-4.9%0.130% 5/14/2025 EntryPoint Capital LLC187,822$419K0.2%+11.3%0.063% 5/13/2025 HighTower Advisors LLC21,486$48K0.0%-69.8%0.007% 5/12/2025 Virtu Financial LLC23,369$52K0.0%N/A0.008% 5/12/2025 Invesco Ltd.24,146$54K0.0%+114.6%0.008% 5/9/2025 JGP Global Gestao de Recursos Ltda.17,346$39K0.0%-23.2%0.006% New Banking Law #1582 Could Unlock $21 Trillion for Americans (Ad)Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…Click here now because they're preparing for what could be the biggest change to our financial syste5/8/2025 XTX Topco Ltd45,253$101K0.0%-50.7%0.015% 5/8/2025 GSA Capital Partners LLP266,895$595K0.1%-54.7%0.089% 5/8/2025 Federated Hermes Inc.947,751$2.11M0.0%+3.4%0.318% 5/7/2025 Baillie Gifford & Co.11,195,832$24.97M0.0%-8.5%3.752% 5/6/2025 Pier 88 Investment Partners LLC243,790$544K0.1%+2.9%0.082% 5/5/2025 Allianz Asset Management GmbH25,622$60K0.0%+121.3%0.009% 5/2/2025 Signaturefd LLC16,447$37K0.0%-71.4%0.006% 4/30/2025 Moloney Securities Asset Management LLC14,400$32K0.0%-84.1%0.005% 4/30/2025 Stratos Wealth Advisors LLC12,000$27K0.0%N/A0.004% 4/23/2025 AssuredPartners Investment Advisors LLC15,356$34K0.0%N/A0.005% 4/22/2025 TrueMark Investments LLC115,391$257K0.1%-7.0%0.039% 4/17/2025 Janney Montgomery Scott LLC13,043$29K0.0%N/A0.004% 4/17/2025 GEM Asset Management LLC30,000$63K0.0%N/A0.010% 4/16/2025 Salem Investment Counselors Inc.78,800$176K0.0%+7.0%0.026% 2/18/2025 Lantern Wealth Advisors LLC18,000$53K0.0%-22.7%0.006% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC4,500,000$13.19M0.0%-2.0%1.524% 2/17/2025 Squarepoint Ops LLC57,685$169K0.0%+333.1%0.020% 2/17/2025 Two Sigma Advisers LP2,608,400$7.64M0.0%+19.8%0.883% 2/17/2025 Two Sigma Investments LP3,257,311$9.54M0.0%+28.6%1.103% 2/17/2025 Tang Capital Management LLC2,582,816$7.57M0.5%+12.3%0.874% 2/17/2025 ProShare Advisors LLC13,990$41K0.0%-19.7%0.005% 2/17/2025 Prosight Management LP7,350,000$21.54M6.0%-19.0%2.488% 2/17/2025 Millennium Management LLC1,482,715$4.34M0.0%+96.7%0.502% 2/17/2025 Lazard Asset Management LLC928,594$2.72M0.0%-15.3%0.314% 2/17/2025 Graham Capital Management L.P.103,610$304K0.0%N/A0.035% 2/17/2025 Brevan Howard Capital Management LP83,519$245K0.0%+548.1%0.028% 2/17/2025 Balyasny Asset Management L.P.13,521$40K0.0%N/A0.005% 2/14/2025 Northern Trust Corp81,621$239K0.0%+106.9%0.028% 2/14/2025 Boothbay Fund Management LLC15,703$46K0.0%N/A0.005% 2/14/2025 Virtus ETF Advisers LLC24,099$71K0.0%-12.9%0.008% 2/14/2025 Stifel Financial Corp71,514$210K0.0%-4.4%0.024% 2/14/2025 Tower Research Capital LLC TRC12,210$36K0.0%-23.6%0.004% 2/14/2025 TD Waterhouse Canada Inc.104,594$306K0.0%-55.0%0.035% 2/14/2025 Capital World Investors7,933,613$23.25M0.0%N/A2.686% 2/13/2025 PEAK6 LLC199,995$586K0.0%N/A0.068% 2/13/2025 Walleye Capital LLC15,000$44K0.0%-94.2%0.005% 2/13/2025 XTX Topco Ltd91,754$269K0.0%N/A0.031% 2/13/2025 Mariner LLC14,540$42K0.0%N/A0.005% 2/13/2025 Barclays PLC38,351$112K0.0%+72.0%0.013% 2/13/2025 Raymond James Financial Inc.19,501$57K0.0%N/A0.007% 2/13/2025 Renaissance Technologies LLC2,486,893$7.29M0.0%-15.6%0.842% 2/13/2025 FIL Ltd24,061$70K0.0%-80.6%0.008% 2/13/2025 ADAR1 Capital Management LLC14,981$44K0.0%-87.0%0.005% 2/13/2025 Bank of Montreal Can51,447$151K0.0%-11.3%0.017% 2/13/2025 Federated Hermes Inc.916,237$2.69M0.0%-59.9%0.310% 2/13/2025 Quadrant Capital Group LLC54,709$160K0.0%+83.4%0.019% 2/13/2025 Envestnet Asset Management Inc.18,428$54K0.0%-20.6%0.006% 2/12/2025 RPO LLC20,937$61K0.1%N/A0.007% 2/12/2025 ExodusPoint Capital Management LP281,795$826K0.0%N/A0.095% 2/12/2025 DKM Wealth Management Inc.10,000$29K0.0%N/A0.003% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $72/12/2025 Diametric Capital LP18,104$53K0.0%N/A0.006% 2/12/2025 Pier 88 Investment Partners LLC236,900$694K0.1%+21.2%0.080% 2/12/2025 DnB Asset Management AS305,579$895K0.0%+424.7%0.103% 2/12/2025 Norges Bank1,284,533$3.76M0.0%N/A0.435% 2/12/2025 JPMorgan Chase & Co.281,033$823K0.0%-21.0%0.095% 2/12/2025 TrueMark Investments LLC124,089$364K0.1%-7.7%0.042% 2/11/2025 EntryPoint Capital LLC168,682$494K0.2%+44.0%0.057% 2/11/2025 Guardian Partners Inc.1,786,414$5.41M0.6%N/A0.605% 2/11/2025 Commonwealth of Pennsylvania Public School Empls Retrmt SYS21,664$63K0.0%N/A0.007% 2/10/2025 Signaturefd LLC57,466$168K0.0%+61.2%0.019% (Data available from 1/1/2016 forward) ABCL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABCL shares? During the previous two years, 123 institutional investors and hedge funds held shares of AbCellera Biologics. The most heavily invested institutionals were Baker BROS. Advisors LP ($124.69M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($34.95M), Baillie Gifford & Co. ($24.97M), Capital World Investors ($23.25M), Prosight Management LP ($21.54M), Orbimed Advisors LLC ($11.47M), and Two Sigma Investments LP ($9.54M).Learn more on AbCellera Biologics' institutional investors. What percentage of AbCellera Biologics' stock is owned by institutional investors? 61.42% of AbCellera Biologics' stock is owned by institutional investors. Learn more on ABCL's institutional investor holdings. Which institutional investors have been buying AbCellera Biologics' stock? Of the 103 institutional investors that purchased AbCellera Biologics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($11.17M), Capital World Investors ($7.93M), Baker BROS. Advisors LP ($4.62M), Norges Bank ($1.92M), Guardian Partners Inc. ($1.79M), Millennium Management LLC ($728.83K), and Two Sigma Investments LP ($723.68K). How much institutional buying is happening at AbCellera Biologics? Institutional investors have bought a total of 28,165,833 shares in the last 24 months. This purchase volume represents approximately $74.87M in transactions. Which of AbCellera Biologics' major shareholders have been selling company stock? Of the 38 institutional investors that sold AbCellera Biologics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baillie Gifford & Co. ($10.72M), Federated Hermes Inc. ($2.26M), Prosight Management LP ($1.73M), Orbimed Advisors LLC ($836.20K), Lazard Asset Management LLC ($491.35K), Renaissance Technologies LLC ($459.81K), and Goldman Sachs Group Inc. ($426.66K). How much institutional selling is happening at AbCellera Biologics? Institutional investors have sold a total of 19,096,996 shares in the last 24 months. This volume of shares sold represents approximately $52.58M in transactions. Related Companies Merus Institutional Ownership CRISPR Therapeutics Institutional Ownership TG Therapeutics Institutional Ownership Cytokinetics Institutional Ownership ACADIA Pharmaceuticals Institutional Ownership Krystal Biotech Institutional Ownership Telix Pharmaceuticals Institutional Ownership ADMA Biologics Institutional Ownership Ascentage Pharma Group International Institutional Ownership Vaxcyte Institutional Ownership This page (NASDAQ:ABCL) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredHave You Seen This? Trump Schedules 'Stock Market Reset' For Sept. 30Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABCL Stock Alerts